Skin cancer: Pathology review

5,846views

Skin cancer: Pathology review

Step 1

Step 1

Tuberculosis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Breast cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Uterine stimulants and relaxants
Aromatase inhibitors
Progestins and antiprogestins
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Osmotic diuretics
Loop diuretics
Potassium sparing diuretics
Carbonic anhydrase inhibitors
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
General anesthetics
Local anesthetics
Neuromuscular blockers
Back pain: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Gout and pseudogout: Pathology review
Seronegative and septic arthritis: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Bone disorders: Pathology review
Bone tumors: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Pigmentation skin disorders: Pathology review
Acneiform skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Skin cancer: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
Inflammatory bowel disease: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Malabsorption syndromes: Pathology review
Diverticular disease: Pathology review
Gastrointestinal bleeding: Pathology review
Appendicitis: Pathology review
Colorectal polyps and cancer: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Vertigo: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hypothyroidism: Pathology review
Hyperthyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes mellitus: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Multiple endocrine neoplasia: Pathology review
Diabetes insipidus and SIADH: Pathology review
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Shock: Pathology review
Hypertension: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Glycogen storage disorders: Pathology review
Dyslipidemias: Pathology review
Lysosomal storage disorders: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review

Transcript

Watch video only

62 year old William comes to the dermatology clinic for a routine skin examination. He has been working as a farmer since the age of 20 and rarely wears a hat or sunscreen. Physical examination reveals a pink, pearly lesion with surrounding telangiectasias on his right upper lip. Right after him, 47 year old Shelby comes in because of a large mole on her right shoulder that has recently grown in size. She is light skinned and has many freckles. Physical examination shows an asymmetric lesion, 8 millimeters in diameter, with irregular borders and variegated brown to black pigmentation.

Based on the initial presentation, both William and Shelby seem to have some form of skin cancer. Okay, first, let’s talk about physiology real quick. Normally, the skin is divided into three main layers, the epidermis, dermis, and hypodermis. The hypodermis is made of fat and connective tissue that anchors the skin to the underlying muscle. Above the hypodermis is the dermis, containing hair follicles, nerve endings, glands, blood vessels and lymphatics. And above the dermis is the epidermis, which contains 5 layers of developing keratinocytes. Keratinocytes start their life at the lowest layer of the epidermis, so the stratum basale or basal layer. As keratinocytes in the stratum basale mature, they migrate into the next layers of the epidermis, called the stratum spinosum, stratum granulosum, stratum lucidum, and finally, the stratum corneum, which is the uppermost and thickest epidermal layer.

Now, the stratum basale also contains the melanocytes, which produce a pigment called melanin from tyrosine. Melanin is then taken up by surrounding keratinocytes, and it contributes to the color of our skin, hair, and eyes. Now, what’s high yield is that melanin acts as a natural sunscreen that absorbs and dissipates, or scatters, UV radiation from the sun or other sources such as tanning booths, preventing it from penetrating the skin.

Now, this is important because UV radiation can damage the DNA of keratinocytes. This occurs mostly through the formation of pyrimidine dimers. Fortunately, most pyrimidine dimers are recognized and repaired by nucleotide excision repair enzymes, which can remove the damaged strand on both sides of the pyrimidine dimer. Now, what’s high yield is that sometimes the repair process doesn’t work and may leave transcriptional errors and mutations. These errors can occur in proto-oncogenes and tumor suppressor genes, increasing the risk of skin cancer. All right, so UV radiation exposure is definitely the number one risk factor for skin cancer, which is why most cases of skin cancer occur on sun-exposed skin regions, particularly the face, ears, neck, and hands. In general, fair skinned individuals are considered to be at a higher risk of developing skin cancer, and the risk increases with sun exposure over time. Other risk factors that affect the protection and repair mechanisms of the skin can also increase the risk of cancer and this include diseases like albinism and xeroderma pigmentosum. Albinism is caused by an autosomal recessive gene mutation encoding any one of the enzymes needed to produce melanin, typically tyrosinase. The result is a dysfunctional or deficient enzyme that drastically decreases the amount of melanin that’s made within normal melanocytes. As a result, there’s reduced or obliterated pigmentation of the skin, hair, and eyes, as well as increased risk of skin cancer. On the other hand, xeroderma pigmentosum is a rare inherited autosomal recessive disorder in which nucleotide excision repair enzymes are defective and cannot repair pyrimidine dimers. Individuals affected by xeroderma pigmentosum are at much higher risk of developing skin cancer. In addition, they can present dry skin, extreme sensitivity to light, and hyperpigmentation in sun exposed areas.

Now, skin cancer can be classified based on the type of skin cell that’s involved. The most common type of skin cancer is basal cell carcinoma, which involves cells in the stratum basale. Most cases occur in middle aged or elderly individuals, and typically appear as well circumscribed, pink, pearly, and waxy elevations of skin with small, dilated blood vessels running over it, also known as telangiectasias. In addition, these lesions can frequently develop central ulceration or crusting. Less commonly, they can appear as non-healing ulcers with infiltrating growth or as scaling plaques. The high yield classic location of a basal cell carcinoma is the upper lip, but are also found on the face and trunk. Basal cell carcinomas tend to be slow growing tumors that rarely metastasize to distant regions of the body, but can be locally invasive, invading into the basement membrane and spreading through the skin and surrounding structures. Diagnosis is based predominantly on clinical examination, although an excisional skin biopsy can be performed both to confirm diagnosis and for treatment. Upon skin biopsy, the classical finding are nests of basaloid cells with peripheral palisading nuclei. Now, the first line treatment is surgical excision, while nonsurgical candidates can get topical therapies such as imiquimod or 5-fluorouracil, curettage, photodynamic therapy, or radiation therapy.

Moving on, the second most common type of skin cancer is squamous cell carcinoma, which has a peak incidence at age 60. Risk factors include not only sun exposure, but also immunosuppression, chronic non-healing wounds, and arsenic exposure. Squamous cell carcinoma typically develops on surfaces exposed to the sun such as cutaneous surface, including the face, ears and hands. There are three stages of squamous cell carcinoma. First, there’s actinic keratosis, which is a precancerous lesion that can appear on sun exposed skin areas as small, erythematous or brownish papules or scaly plaques. The key here is that the lesion typically has a rough, sandpaper-like texture, along with central scaling. On skin biopsy, there are atypical keratinocytes that involve partial thickness of the epidermis only, while sparing the dermis. For treatment, topical chemotherapeutic agents like 5-fluorouracil can be given, as well as surgery, cryotherapy, or photodynamic therapy. After being treated, individuals should undergo frequent monitoring as a small percentage of actinic keratosis can go on to become squamous cell carcinomas.

Next, there’s Bowen disease, which is also called squamous cell carcinoma in situ, because it’s a cancerous lesion, but it does not extend into the dermis. It usually appears as small, erythematous, scaly, and well circumscribed elevations of the skin. They can often be confused for actinic keratosis, but they are typically more red and scaly, and can be tender and bleed. On skin biopsy, Bowen disease presents atypical keratinocytes that involve the full thickness of the epidermis without infiltration into the dermis. Treatment options are the same as those for actinic keratosis, followed by frequent monitoring for progression as well.

Finally, invasive squamous cell carcinoma can break through the basement membrane, extend into the dermis, and it may even reach the hypodermis. Now, squamous cell carcinoma rarely metastasizes, but it is more likely to do so than basal cell carcinoma. Another high yield contrast is that basal cell carcinoma typically appears on the upper lip, while squamous cell carcinoma typically appears on the lower lip. As for its clinical appearance, squamous cell carcinoma can appear as a firm, red, and well circumscribed elevation of the skin. As the lesion grows, the center may become necrotic and can eventually turn into an ulcer. In addition, some lesions may be painful or pruritic. The diagnosis is clinical, followed by excisional skin biopsy performed both to confirm diagnosis and for treatment. On skin biopsy, invasive squamous cell carcinomas have atypical keratinocytes that involve the full thickness of the epidermis, and penetrate the basement membrane into the dermis and deeper tissues. Another classic histologic finding to keep in mind is the formation of keratin pearls, which are deposits of keratin that are surrounded by concentric layers of atypical keratinocytes. First line treatment is surgical excision, but radiation, chemotherapy, or immunotherapy may also be options. And again, after getting successful treatment, individuals should be followed up.

Key Takeaways

Skin cancer is a type of cancer that develops in the cells of the skin. Three main types of skin cancer are basal cell carcinoma (the most common), squamous cell carcinoma (the second most common), and the least common but most deadly, melanoma. Risk factors for skin cancer include exposure to UV radiation, a history of sunburns, fair skin, and a weakened immune system. Diagnosis is made with a tissue biopsy and treatments can include physically removing cells with a high risk of developing into skin cancer. Tumor cells are also commonly removed and treated with radiation, chemotherapy, or immunotherapy.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Skin Cancer Epidemiology, Detection, and Management" Medical Clinics of North America (2015)
  4. "Epidemiology and Economic Burden of Nonmelanoma Skin Cancer" Facial Plastic Surgery Clinics of North America (2012)
  5. "World Cancer Report 2014" NA (2014)
  6. "Ultraviolet radiation" Chronic Diseases and Injuries in Canada (2010)
  7. "Nonmelanoma Skin Cancer" Facial Plastic Surgery Clinics of North America (2013)
  8. "A Clinical Atlas of 101 Common Skin Diseases" NA (2000)
  9. "Basal Cell Carcinoma and Seborrheic Keratosis" International Journal of Surgical Pathology (2015)